TY - JOUR
T1 - An International Survey on the Use of a Polyrevitalizing Solution With or Without Other Aesthetic Procedures in the Daily Practice of Aesthetic Physicians
AU - Fanian, Ferial
AU - Casabona, Gabriela
AU - Bartoletti, Emanuele
AU - Cartier, Hugues
AU - Landau, Marina
AU - Galadari, Hassan
AU - Bageorgou, Fotini
AU - Ogilvie, Alexandra
AU - Theodorakopoulou, Elina
AU - Arteaga, Ariana
AU - Gokalp, Hilal
AU - Pisal, Philippe Hamida
AU - Lopez, Ingrid Gerhke
AU - Rucinski, Gabriel
AU - Chebbah, Myriam
AU - Le Clanche, Solenn
AU - Varlet, Alice Anaïs
AU - Sukmanskaya, Natalia
AU - Issa, Hanane
AU - Philippon, Valerie
AU - Stratigos, Alexander
N1 - Publisher Copyright:
© 2024 The Author(s). Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
PY - 2025/2
Y1 - 2025/2
N2 - Objective: NCTF135HA, a versatile polyrevitalizing solution, is a potent agent for enhancing skin quality, radiance, moisture, vitality, and diminishing fine wrinkles caused by aging factors. Data demonstrate a divergence in its application from skin quality enhancement to treatment of vitiligo lesions. To know more precisely about the protocol of use among providers, alone or in combination with other procedures, we performed an international survey. Method: A Steering Committee of dermatologists, aesthetic surgeons, and physicians developed a 32-question questionnaire based on a literature review. Hosted online from January to March 2024, it targeted healthcare professionals experienced in polyrevitalization. Responses were analyzed anonymously and reported descriptively. Results: Practitioners adopt a balanced approach: half of their patients receiving classic Polyrevitalization (NCTF135HA alone) and the other half undergoing combination therapy (NCTF135HA with another aesthetic procedure). Most administer NCTF135HA across multiple sessions, typically three (39.7%). In combination therapy, 55.5% of practitioners use NCTF135HA for medical purposes, targeting Melasma (53.1%) and Rosacea (45.0%) for instance. Aesthetic use is prevalent, with 94.2% employing NCTF135HA for skin wrinkles (79.9%), and refreshment, rejuvenation, and hydration (73.4%). Combining NCTF135HA with hyaluronic acid (71.2%) and botulinum toxin (49.1%) is common, alongside microneedling (50.2%), peelings (32.4%), and fractional radiofrequency (25.6%). Limitations and Conclusion: Our survey showed a homogenous distribution of NCTF135HA utilization, indicating a consensus on its application across diverse demographics. This consistency highlights its widespread acknowledgment and efficacy in various aesthetic and clinical settings. Limitations include a large respondent group from Mexico and many respondents with less than 10 years of experience.
AB - Objective: NCTF135HA, a versatile polyrevitalizing solution, is a potent agent for enhancing skin quality, radiance, moisture, vitality, and diminishing fine wrinkles caused by aging factors. Data demonstrate a divergence in its application from skin quality enhancement to treatment of vitiligo lesions. To know more precisely about the protocol of use among providers, alone or in combination with other procedures, we performed an international survey. Method: A Steering Committee of dermatologists, aesthetic surgeons, and physicians developed a 32-question questionnaire based on a literature review. Hosted online from January to March 2024, it targeted healthcare professionals experienced in polyrevitalization. Responses were analyzed anonymously and reported descriptively. Results: Practitioners adopt a balanced approach: half of their patients receiving classic Polyrevitalization (NCTF135HA alone) and the other half undergoing combination therapy (NCTF135HA with another aesthetic procedure). Most administer NCTF135HA across multiple sessions, typically three (39.7%). In combination therapy, 55.5% of practitioners use NCTF135HA for medical purposes, targeting Melasma (53.1%) and Rosacea (45.0%) for instance. Aesthetic use is prevalent, with 94.2% employing NCTF135HA for skin wrinkles (79.9%), and refreshment, rejuvenation, and hydration (73.4%). Combining NCTF135HA with hyaluronic acid (71.2%) and botulinum toxin (49.1%) is common, alongside microneedling (50.2%), peelings (32.4%), and fractional radiofrequency (25.6%). Limitations and Conclusion: Our survey showed a homogenous distribution of NCTF135HA utilization, indicating a consensus on its application across diverse demographics. This consistency highlights its widespread acknowledgment and efficacy in various aesthetic and clinical settings. Limitations include a large respondent group from Mexico and many respondents with less than 10 years of experience.
KW - NCTF135HA
KW - Polyrevitalization
KW - combination therapy
UR - http://www.scopus.com/inward/record.url?scp=85215673287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85215673287&partnerID=8YFLogxK
U2 - 10.1111/jocd.16623
DO - 10.1111/jocd.16623
M3 - Article
C2 - 39840703
AN - SCOPUS:85215673287
SN - 1473-2130
VL - 24
JO - Journal of Cosmetic Dermatology
JF - Journal of Cosmetic Dermatology
IS - 2
M1 - e16623
ER -